TFAP2D staining was significantly associated with adverse tumor features, including advanced tumor stage, high Gleason grade, presence of lymph node metastasis (p < 0.0001 each) and a positive surgical margin (p = 0.0045, Table 2). This evidence concerns the gene TFAP2D and metastatic malignant neoplasm in the lymph nodes.